A phase Ib extension study of cancer sternness inhibitor BB608 (napabucasin) in combination with gemcitabine and nab-paclitaxel (nab-PTX) in patients (pts) with metastatic pancreatic cancer.

被引：6
|
作者：
El-Rayes, Bassel F.
Shanda, Safi
Starodub, Alexander
O'Neil, Bert H.
Hanna, Wahid Tewfik
Shaib, Walid Labib
Oh, Cindy
Li, Wei
Li, Youzhi
Borodyansky, Laura
Li, Chiang
Bekaii-Saab, Tanios S.
机构：
[1] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
[3] Indiana Univ, Hlth Goshen Ctr Canc Care, Bloomington, IN 47405 USA
[4] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[5] Univ Tennessee, Med Ctr, Knoxville, TN USA
[6] Boston Biomed Inc, Boston, MA USA
[7] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_supp1.4128
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4128
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Results of a phase I study of GS-5745 in combination with gemcitabine and nab-paclitaxel in patients (pts) with advanced pancreatic cancer.
    Bendell, Johanna C.
    Huang, Xi
    Smith, Victoria
    Maltzman, Julia D.
    Starodub, Alexander
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma
    Grierson, Patrick M.
    Tan, Benjamin
    Pedersen, Katrina S.
    Park, Haeseong
    Suresh, Rama
    Amin, Manik A.
    Trikalinos, Nikolaos A.
    Knoerzer, Deborah
    Kreider, Brent
    Reddy, Anupama
    Liu, Jingxia
    Der, Channing J.
    Wang-Gillam, Andrea
    Lim, Kian-Huat
    ONCOLOGIST, 2023, 28 (02): : E115 - E123
  • [23] Phase II study of pirfenidone combined with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer
    Guo, Guifang
    Li, Shengping
    Mao, Yize
    Yang, Qiuxia
    Yao, Zehui
    Wang, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
    Weiss, Glen J.
    Blaydorn, Lisa
    Beck, Julia
    Bornemann-Kolatzki, Kirsten
    Urnovitz, Howard
    Schutz, Ekkhard
    Khemka, Vivek
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (01) : 96 - 102
  • [25] Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
    Glen J. Weiss
    Lisa Blaydorn
    Julia Beck
    Kirsten Bornemann-Kolatzki
    Howard Urnovitz
    Ekkhard Schütz
    Vivek Khemka
    Investigational New Drugs, 2018, 36 : 96 - 102
  • [26] Gemcitabine (Gem) and nab-paclitaxel (nab-P) in patients (pts) with refractory advanced pancreatic cancer
    Palacio, Sofia
    Akunyili, Ikechukwu Immanuel
    Ernani, Vinicius
    Macintyre, Jessica
    Merchan, Jaime R.
    Pollack, Terri
    Reis, Isildinha
    Restrepo, Maria H.
    Lima, Caio Max S. Rocha
    Hosein, Peter Joel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [27] A phase Ib/II pilot trial with nab-paclitaxel plus gemcitabine plus cisplatin in patients (pts) with stage IV pancreatic cancer.
    Jameson, Gayle S.
    Borazanci, Erkut Hasan
    Babiker, Hani M.
    Poplin, Elizabeth
    Niewiarowska, Anna A.
    Gordon, Michael S.
    Barrett, Michael T.
    Ansaldo, Karen
    Lebron, Leticia
    Stoll, Amy C.
    Rosenthal, Adam
    Shemanski, Lynn R.
    Korn, Ronald Lee
    Ramanathan, Ramesh K.
    Von Hoff, Daniel D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [28] A phase II study of Chinese patients (pts) treated with nab-paclitaxel (nab-P) plus gemcitabine (Gem) for metastatic pancreatic cancer (MPC)
    Shen, Lin
    Yu, Xianjun
    Hao, Jihui
    Wang, Liwei
    Pan, Hongming
    Han, Guohong
    Xu, Jian-Ming
    Zhang, Yanqiao
    Yang, Shujun
    Chen, Jia
    Ying, Jieer
    Dai, Guanghai
    Li, Mingyu
    Begic, Damir
    Lu, Brian D.
    Xu, Ruihua
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [29] Gemcitabine and nab-paclitaxel in patients with unresectable/borderline resectable pancreatic cancer.
    Thapaliya, P.
    Kundranda, M. N.
    Curtis, K. K.
    Callister, M. D.
    Ashman, J. B.
    Collins, J.
    Moss, A.
    Mekeel, K. L.
    Silva, A. C.
    Borad, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
    Pijnappel, Esther N.
    Wassenaar, Nienke P. M.
    Gurney-Champion, Oliver J.
    Klaassen, Remy
    van der Lee, Koen
    Pleunis-van Empel, Marjolein C. H.
    Richel, Dick J.
    Legdeur, Marie C.
    Nederveen, Aart J.
    van Laarhoven, Hanneke W. M.
    Wilmink, Johanna W.
    CANCERS, 2021, 13 (19)
12345